Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SU11248 (Sutent) in locally advanced or metastatic hepatocellular carcinoma
2005-005732-27Phase 2Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in hepatocellular carcinoma (HCC), sponsored by Policlinico Gemelli. Started Dec 2006; status: terminated.
02
Drugs
sunitinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2005-005732-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005732-27.